NO20010390D0 - Behandling av angstsykdommer - Google Patents

Behandling av angstsykdommer

Info

Publication number
NO20010390D0
NO20010390D0 NO20010390A NO20010390A NO20010390D0 NO 20010390 D0 NO20010390 D0 NO 20010390D0 NO 20010390 A NO20010390 A NO 20010390A NO 20010390 A NO20010390 A NO 20010390A NO 20010390 D0 NO20010390 D0 NO 20010390D0
Authority
NO
Norway
Prior art keywords
treatment
anxiety disorders
anxiety
disorders
Prior art date
Application number
NO20010390A
Other languages
English (en)
Other versions
NO20010390L (no
Inventor
Lee Alan Phebus
Tammy Joy Sajdyk
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20010390D0 publication Critical patent/NO20010390D0/no
Publication of NO20010390L publication Critical patent/NO20010390L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20010390A 1998-07-27 2001-01-23 Behandling av angstsykdommer NO20010390L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9431098P 1998-07-27 1998-07-27
PCT/US1999/015475 WO2000006082A2 (en) 1998-07-27 1999-07-08 Treatment of anxiety disorders

Publications (2)

Publication Number Publication Date
NO20010390D0 true NO20010390D0 (no) 2001-01-23
NO20010390L NO20010390L (no) 2001-03-13

Family

ID=22244420

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010390A NO20010390L (no) 1998-07-27 2001-01-23 Behandling av angstsykdommer

Country Status (14)

Country Link
EP (1) EP0976747A3 (no)
JP (1) JP2003527305A (no)
KR (1) KR20010072064A (no)
CN (1) CN1315830A (no)
AU (1) AU4977899A (no)
BR (1) BR9913348A (no)
CA (1) CA2338740A1 (no)
EA (1) EA200100182A1 (no)
HU (1) HUP0102886A3 (no)
IL (1) IL140540A0 (no)
NO (1) NO20010390L (no)
PL (1) PL366197A1 (no)
TR (1) TR200100240T2 (no)
WO (1) WO2000006082A2 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2049601A (en) 1999-12-20 2001-07-03 Eli Lilly And Company Benzofuran derivatives
ES2220582T3 (es) * 1999-12-20 2004-12-16 Eli Lilly And Company Derivados de piperidina y su uso como antagonistas de receptor de serotonina.
US7144898B2 (en) 1999-12-20 2006-12-05 Eli Lilly And Company Indole derivatives for the treatment of depression and anxiety
US20090043117A1 (en) * 2005-02-17 2009-02-12 Bayer Cropscience Aktiengesellschaft Process For Preparing (Disubstitutedpropenyl) Phenylalkyl Substituted Dihydrobenzofurans
BRPI0607720A2 (pt) * 2005-02-17 2009-10-06 Bayer Cropscience Ag processo aperfeiçoado para a preparação de diidrobenzofuranos substituìdos por (propenil dissubstituìdos) fenilalquila
JP2008534507A (ja) * 2005-03-23 2008-08-28 バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト 殺虫活性を有する（二置換プロペニル）フェニルアルキル置換ジヒドロベンゾフランを調製するための改善された方法
CN107973766B (zh) * 2016-10-21 2020-06-19 石家庄诚志永华显示材料有限公司 含有环烷基的氧芴衍生物的液晶化合物及其应用
TWI744458B (zh) * 2017-02-27 2021-11-01 日商捷恩智股份有限公司 具有二苯并呋喃環的化合物、液晶組成物及液晶顯示元件

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2941597A1 (de) * 1979-10-13 1981-04-23 Basf Ag, 6700 Ludwigshafen Piperidinderivate von 4,5-dialkyl-3-hydroxy-pyrrol-2-carbonsaeureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
US5698571A (en) * 1994-10-05 1997-12-16 Eli Lilly And Company 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists

Also Published As

Publication number Publication date
KR20010072064A (ko) 2001-07-31
WO2000006082A3 (en) 2000-05-04
EP0976747A3 (en) 2000-09-13
NO20010390L (no) 2001-03-13
HUP0102886A3 (en) 2002-12-28
EP0976747A2 (en) 2000-02-02
WO2000006082A2 (en) 2000-02-10
HUP0102886A2 (en) 2002-06-29
PL366197A1 (en) 2005-01-24
BR9913348A (pt) 2001-06-12
TR200100240T2 (tr) 2002-01-21
AU4977899A (en) 2000-02-21
EA200100182A1 (ru) 2001-08-27
CN1315830A (zh) 2001-10-03
CA2338740A1 (en) 2000-02-10
IL140540A0 (en) 2002-02-10
JP2003527305A (ja) 2003-09-16

Similar Documents

Publication Publication Date Title
NO993051D0 (no) Intranasale formuleringer for behandling av seksuelle forstyrrelser
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
NO20012995L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
ID27191A (id) Metode untuk pengobatan insomnia
NO20020062L (no) Behandling av nevrotiske forstyrrelser
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20032156D0 (no) Behandling av angstforstyrrelser
NO20010390D0 (no) Behandling av angstsykdommer
NO20024236L (no) Behandling av psoriasis
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
NO20023803D0 (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
IL126681A0 (en) Treatment of trauma-related conditions
NO952411D0 (no) Midler for behandling av metaboliske bensykdommer
DK82798A (da) Treatment of GABA-uptake related disorders
NO20005286D0 (no) Behandling av generelle angstforstyrrelser med paroxetine
NO20005351D0 (no) Paroksetin 10-kamfersulfonat for behandling av CNS lidelser
NO996166D0 (no) Fremgangsmåte for behandling av avluter
UA25221A (uk) Спосіб лікуваhhя розладів цеhтральhої hервової системи

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application